Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Jun;75(6):1431-5.
doi: 10.1016/j.urology.2009.11.076. Epub 2010 Mar 17.

The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer

Affiliations
Comparative Study

The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer

Brett S Carver et al. Urology. 2010 Jun.

Abstract

Objectives: To evaluate the prognostic significance of the total number of lymph nodes obtained at postchemotherapy retroperitoneal lymph node dissection (PC-RPLND). After the multidisciplinary management of metastatic germ cell tumor, approximately 10%-15% of patients with the histologic finding of fibrosis or teratoma will suffer disease recurrence.

Methods: Between 1989 and 2006, a total of 628 patients underwent PC-RPLND and were found to have either fibrosis or teratoma. After Institutional Review Board approval, complete clinical and pathologic data were obtained from our prospective testis cancer surgical database. A Cox proportional hazards regression model was constructed to evaluate the association of the total number of lymph nodes obtained at PC-RPLND on disease recurrence.

Results: On pathologic evaluation, 248 (57%) patients had fibrosis and 184 (43%) patients had teratoma. The median number of lymph nodes resected was 25 (interquartile range, 15-37). On multivariable analysis, increasing postchemotherapy nodal size and decreasing lymph node counts were significant predictors of disease recurrence (P=.01, .04, respectively). For patients with 10 nodes removed, the predicted 2-year relapse free probability was 90%, compared with 97% when 50 nodes were removed.

Conclusions: Our data suggest that the total number of lymph nodes removed and analyzed is an independent predictor of disease recurrence after PC-RPLND. This has implications both for the urologist to assure completeness of resection and for the pathologist to meticulously assess the pathologic specimens.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Total number of lymph nodes removed according to retroperitoneal nodal size
Figure 2
Figure 2
Predicted 2-year relapse-free probability by number of nodes removed, adjusting for nodal size. Dashed line: number of nodes modeled with cubic splines; Solid line: number of nodes modeled with a quadratic term. Unadjusted Kaplan-Meier estimates of the 2-year relapse-free probability for patients with x nodes removed are given as a scatter-plot.

Similar articles

Cited by

References

    1. Bosl G, Bajorin D, Sheinfeld J, Motzer R, Chaganti R. Cancer of the Testis. In: Devita Y, Hellman S, Rosenberg S, editors. Cancer: Principles and practice of oncology. Philidelphia: JB Lippincott; 2000. pp. 1491–1518.
    1. Toner GC, Panicek DM, Heelan RT, Geller NL, Lin SY, Bajorin D, et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol. 1990;8:1683–1694. - PubMed
    1. Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors. J Clin Oncol. 2007;25:5603–5608. - PubMed
    1. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570–3575. - PubMed
    1. Touijer K, Rabbani F, Otero JR, Secin FP, Eastham JA, Scardino PT, Guillonneau B. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% J Urol. 2007;178:120–124. - PubMed

Publication types

MeSH terms